FDA Inspection 1012897 — Minsheng Group Shaoxing Pharmaceutical Co., Ltd.
The FDA completed an inspection of Minsheng Group Shaoxing Pharmaceutical Co., Ltd. on April 14, 2017 in Shaoxing. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- April 14, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Shaoxing (China)